MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI
MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI
批准号:
6017854
负责人:
HENRI C VAN DER HEYDE
金额:
$1.34万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2001-06-30
关键词:
B lymphocyte Plasmodium SCID mouse affinity chromatography cell mediated cytotoxicity cellular immunity enzyme linked immunosorbent assay flow cytometry fluorescence microscopy gas chromatography genetically modified animals helper T lymphocyte humoral immunity immunoregulation interferon gamma interleukin 10 interleukin 2 interleukin 4 laboratory mouse leukocyte activation /transformation macrophage malaria monoclonal antibody polymerase chain reaction western blottings
中文摘要
尽管多年来为征服疟疾作出了大量努力,但它仍然是一个
传染病导致的主要死亡原因最近出现的
抗药性疟疾寄生虫和杀虫剂的发展
由蚊媒共同产生抗药性,
基于免疫的治疗或预防非常理想。为此,需要
对疟疾抗原免疫反应的详细了解。
CD 4 + T细胞被认为是必不可少的决议,
血液阶段疟疾(在这个建议中检查的阶段),但很少
关于CD 4 + T细胞如何影响保护性效应子的研究
机制等解决不同啮齿动物引起的急性感染
不同种类的疟原虫似乎使用不同的分解机制,
约氏疟原虫被抗体介导的免疫(AMI)抑制,
P.查鲍迪通过细胞介导的免疫。我们的目标是利用这些物种
阐明CD 4 + T细胞在疟原虫中的分子机制,
细胞通过分化成不同的Th细胞表型来调节B
细胞和巨噬细胞的功能。为了实现这一目标,我们
打算首先详细研究Th细胞分化及其
解决感染的要求。这些发现将是
随后的研究旨在确定Th细胞-
分化影响保护性抗体的选定参数
发育和巨噬细胞的功能。我们也要谈谈
抗体是否增强体内巨噬细胞功能问题
清除血液中的寄生虫这些研究的结果将有助于
未来实验的设计对我们理解
负责解决疟疾的保护性免疫机制
在人类身上。
英文摘要
Despite many years of intensive effort to conquer malaria, it remains a
leading cause of death due to an infectious disease. The recent advent
of drug-resistant malarial parasites and the development of insecticide
resistance by the mosquito vector jointly make the development of
immune-based therapy or prophylaxis highly desirable. To do so, requires
a detailed understanding of the immune response to malarial antigens.
CD4+ T cells are believed to be essential for the resolution of
bloodstage malaria (the stage examined in this proposal), but little is
known about how CD4+ T cells actually influence protective effector
mechanisms. Resolution of acute infections caused by different rodent
species of Plasmodium appear to use distinct mechanisms of resolution,
with P. yoelii being suppressed by antibody-mediated immunity (AMI) and
P. chabaudi by cell-mediated immunity. Our goal is to use these species
of Plasmodium to elucidate the molecular mechanisms whereby CD4+ T
cells, by differentiating into distinct Th cell-phenotypes, regulate B
cell and macrophage function during malaria. To address this goal, we
intend to first examine in detail Th cell-differentiation and its
requirement for resolution of infection. These findings will be
incorporated into subsequent studies aimed at identifying how Th cell-
differentiation affects selected parameters of protective antibody
development and macrophage function during malaria. We will also address
the question of whether antibodies augment macrophage function in vivo
to clear parasites from blood. The results of these studies will aid in
the design of future experiments crucial to our understanding of
protective immune mechanisms responsible for the resolution of malaria
in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel nanoparticles function as chemo- and adjunctive-therapy against experimental cerebral malaria
-
批准号:10308498
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2020
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Role of platelet CD40 in experimental cerebral malaria coagulopathy
-
批准号:8035475
-
项目类别:
-
资助金额:$9.65万
-
财政年份:2010
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Citrulline adjunctive therapy for cerebral malaria
-
批准号:8089237
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2010
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Role of platelet CD40 in experimental cerebral malaria coagulopathy
-
批准号:7880276
-
项目类别:
-
资助金额:$9.75万
-
财政年份:2010
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Citrulline adjunctive therapy for cerebral malaria
-
批准号:7898993
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2010
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
ABI-PRISM 7700 TO ASSESS MRNA AND DNA
-
批准号:2805356
-
项目类别:
-
资助金额:$11.88万
-
财政年份:1999
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI
-
批准号:6169768
-
项目类别:
-
资助金额:$19.46万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI
-
批准号:2887355
-
项目类别:
-
资助金额:$22.0万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Cell adhesion molecules in cerebral malaria.
-
批准号:6935256
-
项目类别:
-
资助金额:$31.76万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Cell adhesion molecules in cerebral malaria.
-
批准号:6690987
-
项目类别:
-
资助金额:$31.76万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI
-
批准号:2672914
-
项目类别:
-
资助金额:$17.99万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
MECHANISMS WHEREBY CD4 T CELLS ACTIVATE AMI AND CMI
-
批准号:2640738
-
项目类别:
-
资助金额:$16.6万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Cell adhesion molecules in cerebral malaria.
-
批准号:6605849
-
项目类别:
-
资助金额:$25.38万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Cell adhesion molecules in cerebral malaria.
-
批准号:6510525
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Cell adhesion molecules in cerebral malaria.
-
批准号:6400150
-
项目类别:
-
资助金额:$25.38万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
Cell adhesion molecules in cerebral malaria.
-
批准号:6801169
-
项目类别:
-
资助金额:$31.76万
-
财政年份:1997
-
负责人:HENRI C VAN DER HEYDE
-
依托单位:
海外基金